Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy

In ACS patients undergoing PCI, clopidogrel pretreatment was associated with significantly lower 30 day all-cause mortality and major adverse cardiovascular events without increased major bleeding events.